IFNG and central nervous system cancer: To determine whether the virus infection of glioma cells subsequently induced an immunostimulatory boost aside from the induction of ICD, we measured the release of IFNγ in cocultures of virus-infected glioma cells and HLA-matched PBMCs, the latter being unaffected by the infection with XVir-N-31 (Supplementary Figure S6).